Site MapCompany InformationContact Us


Yasmin Lawsuit Attorneys

If you, or a loved one, have experienced serious complications as a result of using an oral contraceptive like Yasmin, you should consult with a Yasmin Litigation Attorney right away. A personal injury lawyer or pharmaceutical attorney can advise you on pursuing a lawsuit and get you the compensation you deserve for your harm.

Yasmin, also known as Yaz or Yas, is a third generation oral birth control pill that was approved by the Food and Drug Administration (FDA) in April 2001, to prevent pregnancy.

The once-daily pill contains two synthetic sex hormones (generic names: drospirenone and ethinyl estradiol) that work together to stop the monthly release of the egg into the uterus. They do this by simulating that ovulation has already occurred.

In addition to its contraception powers, Yasmin also regulates a woman’s menstrual cycle, lessens blood loss and the pain associated with some periods (dysmenorrhea), and decreases the risk of ovarian cysts, common growths on the ovaries that are usually benign but can be painful.

Part of Yasmin’s appeal is that it also helps clear the skin of acne blemishes. Despite user reports of blemish control, the drug is not approved by the FDA to treat acne.

Disadvantages to Yasmin users are serious side effects most often seen in women who smoke or who have a history of heart problems. Women who are pre-disposed to hyperkalemia, or elevated potassium levels, could be placed at serious risk for heart arrhythmia leading to embolism and death. Reports on whether the drug is safe for diabetics or anemics are not conclusive.

Women who are pregnant or soon want to become pregnant should not use Yasmin or other oral contraceptives because they can cause birth defects in unborn babies.

From 2005 to 2006, approximately 7.5 million prescriptions for third generation birth control pills, such as Yasmin, were filled by American women. The high demand may have been based on early reports of Yasmin’s safety.

In 2007, Yasmin generated almost $500 million in revenue for its U.S. manufacturer, Bayer, causing other drug companies to seek generic copycats to market for their own profit.

The Yasmin brand was so popular that it led to a lawsuit between drug companies regarding who could sell the generic brands. On June 24, 2008, Bayer and Barr Laboratories Inc. signed a U.S. marketing agreement for Yasmin® and YAZ®. Bayer agreed to supply Barr with the generic version of Yasmin, beginning on July 1, with the rights to market the contraceptive in the U.S. only. Barr was required to pay Bayer a percentage of its sales.

 In October 2008, misleading Yasmin television ads provoked the FDA to send a critical letter to manufacturer Bayer, demanding that the commercials be pulled. The agency said that the contraception ads downplayed Yasmin’s risks. In the ad, happy women were shown running, driving and singing, thereby giving viewers the false impression that the drug is safe.

The FDA also objected to the depiction of Yasmin as a useful treatment for acne. The ads showed women with blemish-free faces while the voiceover claimed that “Yaz” can help keep the complexion clear.

Buyer Beware
In March 2007, the consumer watchdog group Public Citizen petitioned the FDA to ban all third generation oral contraceptives, like Yasmin, due to their doubled risk of blood clots over second generation oral contraceptives (i.e., 30 cases compared to 15 cases for every 100,000 users per year).

The difference between the two classes of drugs is the formulas’ progestin component. Third generation brands use either drospirenone (DRSP) or desogestrel, which allow for lower hormone doses than the earlier formulations.

Makers of Yasmin, however, maintain that the pill’s reliance on the progestin DRSP removes it from the ranks of newer drugs that carry a high risk of causing cardiovascular problems. That claim is dampened by reports of serious injury and death.

DRSP may increase the body’s potassium levels, which can be life threatening for those with certain health conditions.

The dangers associated with DRSP represent only a part of Yasmin’s potential health detriments. Public Citizen listed Yasmin on its “Worst Pills” list because of the numerous side effects related to its use.

Read More About Yasmin Legal Claims
Sponsored Links


Copyright ©2017 WCIS Media, LLC. All rights reserved
Site Design, Search Engine Optimization, & Content provided by Digital Footprint Media.
VOIP & Data Services Provided by DLJ Management .
The content contained on the web site has been prepared for WCIS Media LLC as a value-add service to it’s legal and medical professionals network, in addition to it’s internet community and in no way is it intended to constitute legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance.